Efficacy and safety of pharmacological interventions for panic disorder with or without agoraphobia: A systematic review and network meta-analysis, accounting for dose
Journal of Affective Disorders · 2026-11 · 122668
DOI: 10.1016/j.jad.2026.122668 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Affective Disorders, 2026-11. Verfasst von Michele Fornaro und 3 weiteren Autor:innen. Beteiligte Einrichtung: Unit of Treatment-Resistant Psychosis, Section of Psychiatry, Department of Neuroscience, Reproductive Science and Dentistry, University School of Me…. Die Arbeit nennt 111 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Panic disorder (PD) features recurrent and unpredictable panic episodes accompanied by a variety of somatic symptoms. This is the first network meta-analysis (NMA) accounting for dose that explores direct and indirect comparisons focusing on pharmacotherapy for PD, with and without agoraphobia. METHODS: We conducted a NMA searching for RCTs comparing pharmacological interventions against each other/or placebo in patients with PD, indexed in PubMed/MEDLINE,Embase,Web-of-Science/Scopus(from inception up to 2026, April 3). Co-primary outcomes were the change in anxiety symptoms/response and the change in weekly frequency of panic attacks. Tolerability/remission/acceptability, as well as the risk of specific adverse events, were secondary outcomes. Confidence-In-Network-Meta-Analysis was appraised. RESULTS: Overall, 92 RCTs, encompassing 36 different treatment combinations, involved 14,510 participants. Sensitivity analysis, including non-sponsored studies only and excluding outliers for major effect modifiers, indicated that brofaromine (SMD = -2.47; 95%CI = -3.57;-1.47), alprazolam (SMD = -0.66; 95%C.I. = -1.11;-0.22), alprazolam sublingual (SMD = -0.61; 95%C.I. = -1.14;-0.06); fluvoxamine (SMD = -0.53; 95%C.I. = -0.79;-0.26), fluoxetine (SMD = -0.52; 95%C.I. = -0.81;-0.22), alprazolam substained-release (SMD = -0.41; 95%C.I. = -0.70;-0.13) outperformed placebo for anxious symptoms reduction. Imipramine, alprazolam, and brofaromine outperformed placebo for response. Fluvoxamine (SMD = -0.33; 95%C.I. = -0.61;-0.04) and alprazolam sustained-release (SMD = -0.30; 95%C.I = -0.58;-0.01) outperformed placebo in the change in weekly frequency of panic attacks. However, a meta-regression of efficacy effect sizes against the adapted AMSTAR-Plus score showed that larger SMDs (i.e., brofaromine) were associated with lower AMSTAR scores, reflecting lower study quality. CONCLUSIONS: Our findings align with previous NMAs and current guidelines, updating and expanding knowledge by concurrently appraising different drugs/doses through refined transitivity/sensitivity analyses.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Unit of Treatment-Resistant Psychosis, Section of Psychiatry, Department of Neuroscience, Reproductive Science and Dentistry, University School of Medicine of Naples Federico II, Naples, Italy. Electronic address: dott.…
- Department of Advanced Biomedical Science-Legal Medicine Section, University of Naples "Federico II", Naples, Italy.
- Department of Biomedical Sciences, Humanitas University, Milan, Italy; ETS Italian Province of Sisters' Hospitallers, Como, Italy; Humanitas Sanpio X, Milan, Italy.
Zitieren
APA
Fornaro, M., Di Lorenzo, C., Caldirola, D., & Perna, G. R. (2026). Efficacy and safety of pharmacological interventions for panic disorder with or without agoraphobia: A systematic review and network meta-analysis, accounting for dose. Journal of Affective Disorders, 122668. https://doi.org/10.1016/j.jad.2026.122668
Vancouver
Fornaro M, Di Lorenzo C, Caldirola D, Perna GR. Efficacy and safety of pharmacological interventions for panic disorder with or without agoraphobia: A systematic review and network meta-analysis, accounting for dose. Journal of Affective Disorders. 2026:122668. doi:10.1016/j.jad.2026.122668
BibTeX
@article{Fornaro2026,
author = {Fornaro, Michele and Di Lorenzo, Chiara and Caldirola, Daniela and Perna, Giampaolo Robert},
title = {Efficacy and safety of pharmacological interventions for panic disorder with or without agoraphobia: A systematic review and network meta-analysis, accounting for dose},
journal = {Journal of Affective Disorders},
year = {2026},
pages = {122668},
doi = {10.1016/j.jad.2026.122668}
}
EUVIMED